NVIDIA Without Jensen, Anthropic IPO Risks & Moderna’s Cancer Vaccine
From Mad Money w/ Jim Cramer · · 44 min
This plays from the publisher's own server. We do not host a copy.
Not rated yet
Description
November 12, 2026; 6pm: Jim Cramer weighs what a Jensen-less NVIDIA could mean for shareholders, breaks down Kraft Heinz’s turnaround pitch and Anthropic’s IPO setup, and interviews Moderna CEO Stéphane Bancel about the company’s cancer vaccine pipeline.
Mad Money Disclaimer (https://cnb.cx/3aAZNN3)
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com (https://pcm.adswizz.com) for information about our collection and use of personal data for advertising.